Health, Medical & Pharma News - Updated Daily page 89

ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease

For patients with immunoglobulin G (IgG)4-related disease, inebilizumab reduces the risk for flares and increases the likelihood of flare-free complete remissio

USPSTF Recommends Early Screening for Syphilis in Pregnancy

The U.S. Preventive Services Task Force (USPSTF) recommends early screening for syphilis infection in all pregnant women (grade A recommendation). This recommen

AI Analysis of Video Can ID Neurologic Changes in the NICU

Deep learning with pose artificial intelligence (AI) may offer a scalable, minimally invasive method for neuro-telemetry in the neonatal intensive care unit (NI

Prenatal Substance Exposure Plays Role in Sleep-Related Sudden Infant Death

Sleep environment characteristics and social drivers of poor health and family vulnerability differ for sleep-related sudden unexplained infant death (SUID) in

There's Been a Big Improvement in Lung Cancer Survival

More people with lung cancer are living longer, but it remains America s deadliest cancer, a new state-by-state report shows. There is more work to do, but I am

U.S. Alcohol-Linked Deaths Doubled in 20 Years

Alcohol-related deaths have surged in the United States, nearly doubling over 20 years, and a growing number of victims are women, a new study warns. Our study

More Than Half of U.S. Adults Could Be Candidates for Ozempic

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as

Why Alarm Is Easing Over a Rise in Pancreatic Cancer Among the Young

Experts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any inc

Judge Declares Wyoming's Abortion Bans Unconstitutional

Two Wyoming abortion bans, including the first state law to prohibit the use of abortion pills, violate the state s constitution, a judge ruled Monday. In her d

Icotrokinra Delivered an Industry-Leading Combination of Significant Skin Clearance with Demonstrated Tolerability in a Once Daily Pill in Phase 3 Topline Results

SPRING HOUSE, Pa. (November 18, 2024) Johnson Johnson (NYSE JNJ) today announced positive topline results from ICONIC-LEADa, a pivotal Phase 3 investigational s

Pharmaceutical News and Articles